700 patients110,866 observations180 daysLIVE

Patient P-02466

Synthetic patientMETA-24 · Day 173 · 25–34 · M · baseline S20Open companion preview
Therapy response
Declining
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
56%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S20

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability+29
  • Nutritional resilience-21
  • Inflammatory activity+13
  • Treatment adherence-4

What helped?

No interventions yet.

    LIFE OS recommendation
    Monitoring Escalation ME-01
    77%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 100% showed improvement
    • median effect visible after 3 days

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 25
      • MicrobiomeF. prausnitzii depleted
    • Inflammatory signalling 20
      • MicrobiomeBacteroides fragilis expansion
    • Autonomic recovery 20
      • WearableShort sleep window
    • Mucosal barrier integrity 10
      • WearableSleep 5.7 h, below personal baseline
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Rapid metabolizer
      Expected exposure
    • GLP1R rs6923761 A
      Altered receptor sensitivity
    Microbiome
    Shannon diversity 2.9 · butyrate capacity 47/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    58 ms
    Sleep
    6.4 h
    Steps
    8,545
    Resting HR
    66 bpm
    Daily log: GI score 37, nutritional resilience 55, adherence 92.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0255452%S1982
    P-0267549%S2088
    P-0237847%S1676
    P-0244347%S1875
    P-0203846%S1577
    P-0217046%S0480
    P-0254346%S1679
    P-0256646%S2081
    P-0258946%S0282
    P-0200645%S1487
    P-0227545%S0184
    P-0225444%S1977